AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 57 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $467,000 | +51.6% | 23,765 | +11.0% | 0.00% | +100.0% |
Q2 2017 | $308,000 | +63.8% | 21,403 | +4.5% | 0.00% | 0.0% |
Q1 2017 | $188,000 | -23.0% | 20,488 | -12.5% | 0.00% | 0.0% |
Q4 2016 | $244,000 | +22.6% | 23,425 | +6.5% | 0.00% | 0.0% |
Q3 2016 | $199,000 | +26.8% | 21,996 | +5.1% | 0.00% | 0.0% |
Q2 2016 | $157,000 | -16.9% | 20,937 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $189,000 | -8.3% | 20,937 | +31.5% | 0.00% | 0.0% |
Q4 2015 | $206,000 | +38.3% | 15,924 | +3.1% | 0.00% | 0.0% |
Q3 2015 | $149,000 | -6.3% | 15,450 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $159,000 | +156.5% | 15,450 | +176.9% | 0.00% | – |
Q1 2015 | $62,000 | -84.5% | 5,580 | -83.7% | 0.00% | -100.0% |
Q4 2014 | $399,000 | +202.3% | 34,286 | +473.9% | 0.00% | +100.0% |
Q3 2014 | $132,000 | -20.5% | 5,974 | +0.1% | 0.00% | 0.0% |
Q2 2014 | $166,000 | – | 5,971 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 4,652,561 | $10,515,000 | 10.70% |
Orchard Capital Management, LLC | 1,593,531 | $3,601,000 | 1.06% |
Nantahala Capital Management | 4,918,565 | $11,116,000 | 0.39% |
Ardent Capital Management, Inc. | 168,811 | $382,000 | 0.25% |
Birchview Capital, LP | 100,000 | $226,000 | 0.15% |
Nantahala Capital Management | 1,000,000 | $2,260,000 | 0.08% |
PDT Partners, LLC | 433,400 | $979,000 | 0.08% |
Woodline Partners LP | 2,231,966 | $5,044,000 | 0.07% |
Virtus ETF Advisers LLC | 69,015 | $156,000 | 0.06% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 2,737,900 | $6,188,000 | 0.04% |